SCHEMBL7085478

SCHEMBL7085478

FC(F)(F)Oc1cccc(-c2cccc3cc[nH]c23)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
XDH P47989 1/20 0.46
ADORA1 P30542 2/20 0.43
ADORA2A P29274 1/20 0.43
KCNH2 Q12809 1/20 0.40
SCN10A Q9Y5Y9 1/20 0.40
PDE10A Q9Y233 2/20 0.39
CTSS P25774 1/20 0.39
CTSK P43235 1/20 0.39
NPY5R Q15761 1/20 0.39
PIM1 P11309 2/20 0.39
PIM3 Q86V86 1/20 0.39
GRM5 P41594 1/20 0.38
NR3C1 P04150 1/20 0.38
GALR1 P47211 1/20 0.38
GHSR Q92847 1/20 0.38
DHODH Q02127 1/20 0.37
TRPV3 Q8NET8 1/20 0.37
DYRK1A Q13627 1/20 0.37
FLT3 P36888 1/20 0.37
PIM2 Q9P1W9 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6326839 0.77 ASH1L (0.51) XDHADORA1ADORA2AKCNH2SCN10A
SCHEMBL28030810 0.75 NPC1 (0.57) XDHADORA1ADORA2AKCNH2SCN10A
SCHEMBL7089072 0.75 GHSR (0.54) XDHADORA1ADORA2AKCNH2SCN10A
SCHEMBL5542629 0.74 ADORA2A (0.47) XDHADORA1ADORA2AKCNH2SCN10A
SCHEMBL5661955 0.73 GSTP1 (0.48) NR3C1AHR
SCHEMBL7088348 0.73 NPC1 (0.49) NR3C1AHR
SCHEMBL594405 0.72 AHR (0.50) NR3C1AHR
SCHEMBL24315292 0.72 ADORA1 (0.48) XDHADORA1ADORA2AKCNH2SCN10A
SCHEMBL5662296 0.72 AHR (0.52) GRM5NR3C1AHR
SCHEMBL20552404 0.72 REN (0.45) NR3C1AHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030203959-A1 Novel modulators of potassium channels 4SC AG (DE) 2003-10-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030203959-A1 Novel modulators of potassium channels HCN3, KCNN3, KCNN1 XDH 2112/4885ADORA1 347/4885ADORA2A 883/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.